Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

A New Bull Market For The ASX 200?

Feb 01 2024 - Technicals

Technical analyst Daniel Goulding considers further upside potential for the Australian share market, and whether current dynamics deserve to be labeled ‘bull market’


Woodside Energy: Head And Shoulders

Jan 31 2024 - Technicals

The Chartist reports a small head-and-shoulders pattern should keep momentum positive in the short term for Woodside Energy shares


Spotlight On ASX-Listed Cannabis Companies

Jan 31 2024 - Small Caps

Some cannabis gems are sprouting in the ASX weed patch, but they are hard to find in the haze of hype, Tim Boreham, Editor, The New Criterion reports


ResMed Recovery Turns Into Hollywood Script

Jan 31 2024 - Australia

More troubles for key competitor Philips/Respironics suggests there could be more momentum shifting in ResMed’s favour


Charter Hall Looks Poised

Jan 30 2024 - Technicals

Michael Gable of Fairmont Equities is signaling momentum seems to have turned for Charter Hall shares, with a fresh Buy signal about to be triggered


ResMed Makes A Comeback

Jan 29 2024 - Australia

ResMed’s December quarter showed long-awaited margin improvement and relieved market fears of the impact of weight-loss drugs


The Market In Numbers – 27 Jan 2024

Jan 27 2024 - Australia

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements


Judo Answers The Critics

Jan 24 2024 - Small Caps

In response to a broker’s negative assessment, Judo Capital has provided a surprise trading update that significantly exceeded expectations


ResMed: The Recovery Has Begun

Jan 23 2024 - Technicals

Michael Gable of Fairmont Equities observes market dynamics for ResMed have changed for the better with price action suggesting higher prices are on the cards


The Market In Numbers – 20 Jan 2024

Jan 20 2024 - Australia

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements


Analyse The Market From A Different Angle